Issues in the management of antiplatelet therapy in patients undergoing surgical revascularization. A roundtable discussion

J Invasive Cardiol. 2005 May;17(5):283-7.

Authors

Deepak L Bhatt¹, Sary Aranki, John Byrne, Devinder Bhatia, Shamir Mehta, Roger Mills

Affiliation

¹ Department of Cardiovascular Medicine, Cleveland Clinic Foundation, 9500 Euclid Avenue, Desk F25, Cleveland, OH, 44195, USA. bhattd@ccf.org

PMID: 15879612

No abstract available

Publication types

Comparative Study
Review

MeSH terms

Angina, Unstable / diagnostic imaging
Angina, Unstable / drug therapy*
Angina, Unstable / mortality
Angina, Unstable / surgery
Angioplasty, Balloon, Coronary / methods
Aspirin / therapeutic use
Clopidogrel
Combined Modality Therapy
Coronary Artery Bypass / methods
Coronary Stenosis / complications
Coronary Stenosis / diagnostic imaging
Coronary Stenosis / drug therapy
Coronary Stenosis / surgery
Female
Humans
Male
Myocardial Revascularization / methods*
Platelet Aggregation Inhibitors / therapeutic use*
Prognosis
Radiography
Risk Assessment
Stents
Survival Rate
Ticlopidine / analogs & derivatives*
Ticlopidine / therapeutic use
Treatment Outcome

Substances

Platelet Aggregation Inhibitors
Clopidogrel
Ticlopidine
Aspirin